- Home
- OPTN vs VIGL Comparison
OPTN vs VIGL Comparison
Compare OPTN & VIGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OPTN
- VIGL
- Stock Information
- Founded
- OPTN 2010
- VIGL 2020
- Country
- OPTN United States
- VIGL United States
- Employees
- OPTN N/A
- VIGL N/A
- Industry
- OPTN Biotechnology: Pharmaceutical Preparations
- VIGL Biotechnology: Pharmaceutical Preparations
- Sector
- OPTN Health Care
- VIGL Health Care
- Exchange
- OPTN Nasdaq
- VIGL Nasdaq
- Market Cap
- OPTN 92.8M
- VIGL 74.7M
- IPO Year
- OPTN 2017
- VIGL 2022
- Fundamental
- Price
- OPTN $9.39
- VIGL $2.42
- Analyst Decision
- OPTN Hold
- VIGL Strong Buy
- Analyst Count
- OPTN 3
- VIGL 5
- Target Price
- OPTN $9.00
- VIGL $16.33
- AVG Volume (30 Days)
- OPTN 32.1K
- VIGL 155.0K
- Earning Date
- OPTN 05-20-2025
- VIGL 05-07-2025
- Dividend Yield
- OPTN N/A
- VIGL N/A
- EPS Growth
- OPTN N/A
- VIGL N/A
- EPS
- OPTN N/A
- VIGL N/A
- Revenue
- OPTN $78,226,000.00
- VIGL N/A
- Revenue This Year
- OPTN $30.49
- VIGL N/A
- Revenue Next Year
- OPTN $13.51
- VIGL N/A
- P/E Ratio
- OPTN N/A
- VIGL N/A
- Revenue Growth
- OPTN 10.20
- VIGL N/A
- 52 Week Low
- OPTN $4.82
- VIGL $1.31
- 52 Week High
- OPTN $20.03
- VIGL $6.06
- Technical
- Relative Strength Index (RSI)
- OPTN 76.14
- VIGL 60.31
- Support Level
- OPTN $9.37
- VIGL $2.28
- Resistance Level
- OPTN $9.45
- VIGL $3.00
- Average True Range (ATR)
- OPTN 0.08
- VIGL 0.27
- MACD
- OPTN -0.07
- VIGL 0.06
- Stochastic Oscillator
- OPTN 80.71
- VIGL 55.38
About OPTN OptiNose Inc.
OptiNose Inc is a specialty pharmaceutical company focuses on the development and commercialization of products for patients treated by ear, nose, and throat (ENT), and allergy specialists. Its first commercial product, XHANCE (fluticasone propionate) nasal spray, 93 microgram (mcg), is a therapeutic utilizing the proprietary Exhalation Delivery System (EDS) that delivers topically-acting corticosteroid for the treatment of chronic rhinosinusitis with and without nasal polyps.
About VIGL Vigil Neuroscience Inc.
Vigil Neuroscience Inc is a clinical-stage biotechnology company engaged in improving the lives of patients, caregivers, and families affected by rare and common neurodegenerative diseases by pursuing the development of disease-modifying therapeutics to restore the vigilance of microglia. Microglia are the sentinel immune cells of the brain and play a critical role in maintaining central nervous system (CNS) health and responding to damage caused by disease. The group provides solutions for fully human monoclonal antibody and Oral small molecule TERM2 agonist.